Navigation Links
bioMETRX, Inc. Acquires Patent for Biometric Padlock
Date:9/5/2007

JERICHO, N.Y., Sept. 5 /PRNewswire-FirstCall/ -- bioMETRX, Inc. (OTC Bulletin Board: BMRX) a leading provider of biometric based consumer products, today announced that it has acquired a patent that covers the adaptation and use of biometrics to secure portable locks.

The company believes that this patent is valuable in the portable lock market. For many years, consumers have been using portable locks, such as padlocks and combination locks, to secure personal belongings in lockers and storage cabinets. These traditional locks have been effective. This patent allows bioMETRX to exclusively improve current mechanical padlocks and combination locks using biometrics, providing users the ability to open portable locks without the need to remember combination codes or carry metal keys.

"The acquisition of this patent confirms the continued commitment of this company to build our intellectual property portfolio as we identify and develop new products for consumers and their busy lifestyles," noted Mark Basile, Chief Executive Officer of bioMETRX, Inc. "Through our growing Patent portfolio, we strengthen our ability to protect our innovative products from competition as we continue to establish smartTOUCH(TM) as the trusted brand in biometric products for the consumer".

The size and scope of the padlock and combination lock market is massive, with an estimated 40 million locks sold totaling in excess of $600 million in the United States alone. The Company expects to work with its current partners to bring a version of a finger activated padlock to market in 2008.

The company's first product, the Master Lock(R) smartTOUCH(TM) garage door opener is scheduled to ship to retailers in a few weeks.

About bioMETRX, Inc.

bioMETRX, Inc. designs, develops and markets biometrics-based products to the consumer market under the common brand name - smartTOUCH(TM); bioMETRX Technologies, Inc. designs and engineers biometrics-based products for t
'/>"/>

SOURCE bioMETRX, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Dinosaur DNA? New Patent Covers Degraded DNA recovery
2. Nanogen Issued Patent for Electronic Microarray With Memory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
(Date:5/17/2013)... residents of all ages will celebrate the science ... on our daily lives during the inaugural Atlanta ... and educators from local museums, corporations, K-12 schools ... 40 different events for children and adults at ... http://atlantasciencefestival.org . , The annual Atlanta Science ...
(Date:5/17/2013)... Efficient and Sustainable Global Logistics Operations) is aiming to ... efficiency of intermodal loading systems and the boosting of ... European organisations with experience in the logistics sector and ... 17,000,000 and a duration of three and a half ... the semantic components and ontologies shared by the users, ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2First Atlanta Science Festival set for 2014 2New logistics services that will cut energy consumption and CO2 emissions 2
... New research suggests a higher-protein, lower-carbohydrate energy-restricted diet has ... fat and increasing lean muscle, particularly when the proteins ... the September issue of the Journal of Nutrition, ... otherwise healthy, premenopausal women. Each consumed either low, ...
... Lithuania, Aug. 29, 2011 Neurotechnology ... technologies, today announced the availability of SentiSight 3.0 ... recognition. This latest version adds shape-based recognition and offers ... SentiSight 2.1. It also includes enhanced tracking of fast ...
... which can stop the formation of long protein strands, ... kidney dialysis patients has been identified by researchers at ... to new methods to identify drugs to prevent, treat ... amyloid fibrils play a part, including Alzheimer,s, Parkinson,s and ...
Cached Biology News:Foods rich in protein, dairy products help dieters preserve muscle and lose belly fat: study 2SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 2SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 3SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 4Research offers new way to target shape-shifting proteins 2
(Date:5/20/2013)... 2013 , Collaboration with ... (ARS) in treatment of mastitis , ... Trials to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will ... Research Service (ARS) to develop and trial products targeting ...
(Date:5/20/2013)... ANGELES , May 20, 2013 Today, ... San Francisco , James McGough ... Clinical Psychiatry at the Semel Institute for Neuroscience and ... of Medicine at the University of California Los ... both Child and Adolescent Psychopharmacology and ADHD at UCLA, ...
(Date:5/20/2013)... With bed bugs' presence come problems in various ... need to be eliminated, one must make sure that the ... And so to help bed bug sufferers get that done, ... bed bugs without using harmful pesticides. In it, the ... Bed Bug Bully. , According to My Cleaning Products, contrary ...
(Date:5/20/2013)... May 20, 2013 Rhythm announced today the ... RM-131, the company,s novel ghrelin agonist for the treatment ... trial demonstrated that RM-131 significantly accelerates early gastric emptying ... diabetic patients with diabetic gastroparesis. The findings were presented ... Orlando and recently published in ...
Breaking Biology Technology:Phosphagenics Signs Research Agreement with the Agricultural Research Service 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 3
... by 45.7%, Profit Attributable to Shareholders ... 14 /Xinhua-PRNewswire/ -- Fufeng Group Limited,("Fufeng" or "the ... corn-based biochemical products in China, today announces,its interim ... 2008., During the period under review, driven ...
... Aug. 14 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... the,discovery, development and commercialization of novel drugs in ... today,announced its financial results for the second quarter ... ), The net loss for the three ...
... Derma Sciences, Inc.,(OTC Bulletin Board: DSCI), a provider ... second quarter and first six months ended,June 30, 2008. ... and,distribution capacity provided by the Company,s new First Aid ... flagship product, MEDIHONEY(R). For,the second quarter in 2008, the ...
Cached Biology Technology:Fufeng Announces 2008 Interim Results With Strong Sign of Recovery 2Fufeng Announces 2008 Interim Results With Strong Sign of Recovery 3Advanced Life Sciences Announces Second Quarter 2008 Financial Results 2Advanced Life Sciences Announces Second Quarter 2008 Financial Results 3Advanced Life Sciences Announces Second Quarter 2008 Financial Results 4Advanced Life Sciences Announces Second Quarter 2008 Financial Results 5Advanced Life Sciences Announces Second Quarter 2008 Financial Results 6Advanced Life Sciences Announces Second Quarter 2008 Financial Results 7Advanced Life Sciences Announces Second Quarter 2008 Financial Results 8Advanced Life Sciences Announces Second Quarter 2008 Financial Results 9Advanced Life Sciences Announces Second Quarter 2008 Financial Results 10Derma Sciences Reports Second Quarter 2008 Results 2Derma Sciences Reports Second Quarter 2008 Results 3Derma Sciences Reports Second Quarter 2008 Results 4Derma Sciences Reports Second Quarter 2008 Results 5
Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...
WTAP Antibody...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
...
Biology Products: